Reprocell Inc operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reprocell Inc with three other
pharmaceutical manufacturers in Asia:
Natural Capsules Limited
sales of 620.53 million Indian Rupees [US$9.48 million]
Star Pharmaceutical Limited
(61.68 million Chinese Renmimbi [US$8.96 million]
Bioalpha Holdings Bhd
based in Malaysia
(47.72 million Malaysian Ringgits [US$10.78 million]
During the year ended March of 2016, sales at
Reprocell Inc were ¥1.07 billion (US$9.60 million).
increase of 88.1%
versus 2015, when the company's sales were ¥567.00 million.
This was the fifth consecutive year of sales increases at Reprocell Inc
(and since 2011, sales have increased a total of 283%).
Sales of Ips Cell Business saw an increase
97.2% in 2016, from
¥507.18 million to ¥999.93 million.